Publications by authors named "Steven Lee Chang"
Introduction: The Health-Related Quality of Life (HRQoL) often declines among cancer survivors due to many factors. Some cancer patients who smoke before the cancer diagnosis continue this harmful habit, potentially contributing to a more significant decline in their HRQoL. Therefore, this study investigates the association between smoking status and HRQoL in cancer survivors.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the link between healthcare professionals' specialties and tobacco use among cancer survivors, revealing a lack of understanding in this area.
- Data from 19,855 cancer survivors were analyzed, with 26.3% identifying as current smokers; urological and gynecological cancer patients showed higher smoking rates compared to those in Malignant Hematology.
- The findings highlight that smoking cessation rates vary by specialty, urging healthcare professionals to play a crucial role in counseling tobacco-related cancer survivors.
Purpose: To better understand whether the marital status impacts 90-day postoperative outcomes following kidney cancer surgery.
Methods: We performed a retrospective cohort study of adult patients undergoing elective partial or radical nephrectomy to manage kidney masses from 2003 to 2017 using the Premier Hospital Database, a national hospital discharge dataset. Multinomial logistic regression models controlling for a wide range of clinicodemographic, surgical, and hospital characteristics were used to assess an association between marital status and postoperative complications.
Background: Even though cytoreductive nephrectomy (CN) was once the standard of care for patients with advanced renal cell carcinoma (RCC), its role in treatment has not been well analyzed or defined in the era of immunotherapy (IO).
Materials And Methods: This study analyzed pathological outcomes in patients with advanced or metastatic RCC who received IO prior to CN. This was a multi-institutional, retrospective study of patients with advanced or metastatic RCC.
Surgery has historically been the mainstay of treatment for metastatic renal cell carcinoma (mRCC), but recent clinical trials demonstrated that contemporary systemic therapies alone are non-inferior to cytoreductive nephrectomy (CN). Thus, the current role of surgery is not precisely defined. CN remains an appropriate upfront treatment for the palliation of severe symptoms, select cases of metastatic non-clear cell renal cell carcinoma, for consolidation following systemic therapy, and in the setting of oligometastatic disease.
View Article and Find Full Text PDFImportance: There is a growing trend toward conservative management for certain low-risk cancers. Hospital and health-system factors may play a role in determining how these patients are managed.
Objective: To explore the contribution of hospitals on patients' odds of nonoperative management for low-risk cancer.